Uwell Biopharma, Inc. (TPEX:7902)

Uwell Biopharma Revenue

Uwell Biopharma had revenue of 35.00K TWD in the twelve months ending June 30, 2026, down -92.22% year-over-year. In the year 2025, Uwell Biopharma had annual revenue of 35.00K, down -92.22%. That makes Uwell Biopharma the 47,630th largest company in the world by revenue and 2,210th in Taiwan.

• Revenue: 35.00K
• Revenue Growth: -92.22%
• P/S Ratio: 160,484.00
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.62B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.00K	-415.00K	-92.22%
Dec 31, 2024	450.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 5, 2026

Data Sources Report a data error